Neuropsychiatric manifestations in CADASIL

Dialogues in Clinical Neuroscience

Volumn 9, Issue 2, 2007, Pages 199-208

  Chabriat, Hugues ^a   Bousser, Marie Germaine ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

CADASIL; Cognitive impairment; Lacunar infarct; Mood disorder; MRI; Notch3; Subcortical ischemic vascular dementia; Vascular; White matter

Indexed keywords

NOTCH3 RECEPTOR;

ARTERY; ARTERY DISEASE; ARTICLE; BEHAVIOR DISORDER; CADASIL; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DEMENTIA; DEPRESSION; GENE MUTATION; HUMAN; INCIDENCE; MENTAL DISEASE; MOOD DISORDER; MULTIINFARCT DEMENTIA; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE;

BRAIN; BRAIN INFARCTION; CADASIL; CEREBRAL ARTERIES; COGNITION DISORDERS; DELIRIUM, DEMENTIA, AMNESTIC, COGNITIVE DISORDERS; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; HUMANS; MOOD DISORDERS;

EID: 34447547507     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (100)

1. Tournier-Lasserve E, Joutel A, Melki J, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet. 1993;3:256-259.
2. Joutel A, Corpechot C, Ducros A, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996;383:707-710.
3. Opherk C, Peters N, Herzog J, Luedtke R, Dichgans M. Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients. Brain. 2004;127(Pt 11):2533-2539.
4. Dichgans M, Mayer M, Uttner I, et al. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol. 1998;44:731-739.
5. Chabriat H, Vahedi K, Iba-Zizen MT, et al. Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet. 1995;346:934-939.
6. Singhal S, Bevan S, Barrick T, Rich P, Markus HS. The influence of genetic and cardiovascular risk factors on the CADASIL phenotype. Brain. 2004;127:2031-2038.
7. Razvi SS, Davidson R, Bone I, Muir KW. The prevalence of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) in the west of Scotland. J Neurol Neurosurg Psychiatry. 2005;76:739-741.
8. Baudrimont M, Dubas F, Joutel A, Tournier-Lasserve E, Bousser MG. Autosomal dominant leukoencephalopathy and subcortical ischemic stroke. A clinicopathological study. Stroke. 1993;24:122-125.
9. Ruchoux MM, Maurage CA. CADASIL: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J Neuropathol Exp Neurol. 1997;56:947-964.
10. Ruchoux MM, Brulin P, Brillault J, Dehouck MP, Cecchelli R, Bataillard M. Lessons from CADASIL. Ann N Y Acad Sci. 2002;977:224-231.
11. Ruchoux MM, Guerouaou D, Vandenhaute B, Pruvo JP, Vermersch P, Leys D. Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Acta Neuropathol (Berl). 1995;89:500-512.
12. Davous P, Fallet-Bianco C. [Familial subcortical dementia with arteriopathic leukoencephalopathy. A clinico-pathological case]. Rev Neurol (Paris). 1991;147:376-384.
13. Pullicino P, Ostow P, Miller L, Snyder W, Muschauer F. Pontine ischemic rarefaction. Ann Neurol. 1995;37:460-466.
14. Okeda R, Arima K, Kawai M. Arterial changes in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) in relation to pathogenesis of diffuse myelin loss of cerebral white matter: examination of cerebral medullary arteries by reconstruction of serial sections of an autopsy case. Stroke. 2002;33:2565-2569.
15. Miao Q, Paloneva T, Tuominen S, et al. Fibrosis and stenosis of the long penetrating cerebral arteries: the cause of the white matter pathology in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Brain Pathol. 2004;14:358-364.
16. Zhang WW, Ma KC, Andersen O, Sourander P, Tollesson PO, Olsson Y. The microvascular changes in cases of hereditary multi-infarct disease of the brain. Acta Neuropathol (Berl). 1994;87:317-324.
17. Gray F, Robert F, Labrecque R, et al. Autosomal dominant arteriopathic leuko-encephalopathy and Alzheimer's disease. Neuropathol Appl Neurobiol. 1994;20:22-30.
18. Mikol J, Henin D, Baudrimont M, et al. [Atypical CADASIL phenotypes and pathological findings in two new French families]. Rev Neurol (Paris). 2001;157:655-667.
19. Bergmann M, Ebke M, Yuan Y, Bruck W, Mugler M, Schwendemann G. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL): a morphological study of a German family. Acta Neuropathol (Berl). 1996;92:341-350.
20. Desmond DW, Moroney JT, Lynch T, et al. CADASIL in a North American family: clinical, pathologic, and radiologic findings. Neurology. 1998;51:844-849.
21. Filley CM, Thompson LL, Sze CI, Simon JA, Paskavitz JF, Kleinschmidt-DeMasters BK. White matter dementia in CADASIL. J Neurol Sci. 1999;163:163-167.
22. Gutierrez-Molina M, Caminero Rodriguez A, Martinez Garcia C, Arpa Gutierrez J, Morales Bastos C, Amer G. Small arterial granular degeneration in familial Binswanger's syndrome. Acta Neuropathol (Berl). 1994;87:98-105.
23. Joutel A, Andreux F, Gaulis S, et al. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest. 2000;105:597-605.
24. Villa N, Walker L, Lindsell CE, Gasson J, Iruela-Arispe ML, Weinmaster G. Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. Mech Dev. 2001;108:161-164.
25. Joutel A, Corpechot C, Ducros A, et al. Notch3 mutations in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), a mendelian condition causing stroke and vascular dementia. Ann N Y Acad Sci. 1997;826:213-217.
26. Joutel A, Tournier-Lasserve E. Notch signalling pathway and human diseases. Semin Cell Dev Biol. 1998;9:619-625.
27. Gray GE, Mann RS, Mitsiadis E, et al. Human ligands of the Notch receptor. Am J Pathol. 1999;154:785-94.
28. Domenga V, Fardoux P, Lacombe P, et al. Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. Genes Dev. 2004;18:2730-2735.
29. Joutel A, Chabriat H, Vahedi K, et al. Splice site mutation causing a seven amino acid Notch3 in-frame deletion in CADASIL. Neurology. 2000;54:1874-1875.
30. Joutel A, Vahedi K, Corpechot C, et al. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet. 1997;350:1511-1515.
31. Dotti MT, Federico A, Mazzei R, et al. The spectrum of Notch3 mutations in 28 Italian CADASIL families. J Neurol Neurosurg Psychiatry. 2005;76:736-738.
32. Peters N, Opherk C, Bergmann T, Castro M, Herzog J, Dichgans M. Spectrum of mutations in biopsy-proven CADASIL: implications for diagnostic strategies. Arch Neurol. 2005;62:1091-1094.
33. Blaumueller CM, Qi H, Zagouras P, Artavanis-Tsakonas S. Intracellular cleavage of Notch leads to a heterodimeric receptor on the plasma membrane. Cell. 1997;90:281-291.
34. Joutel A, Francois A, Chabriat H, et al. [CADASIL: genetics and physiopathology]. Bull Acad Natl Med. 2000;184:1535-1542; discussion 1542-1544.
35. Joutel A, Tournier-Lasserve E. [Molecular basis and physiopathogenic mechanisms of CADASIL: a model of small vessel diseases of the brain]. J Soc Biol. 2002;196:109-115.
36. Robinson W, Galetta SL, McCluskey L, Forman MS, Baker LJ. Retinal findings in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (cadasil). Surv Ophthalmol. 2001;45:445-448.
37. Brulin-Fardoux P, Godfrain C, Maurage CA, et al. Glycohistochemical characterization of vascular muscle cell destruction in CADASIL subjects by lectins, neoglycoconjugates and galectin-specific antibodies. Neuropathol Appl Neurobiol. 2003;29:400-410.
38. Schroder JM, Sellhaus B, Jorg J. Identification of the characteristic vascular changes in a sural nerve biopsy of a case with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Acta Neuropathol (Berl). 1995;89:116-121.
39. Goebel HH, Meyermann R, Rosin R, Schlote W. Characteristic morphologic manifestation of CADASIL, cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy, in skeletal muscle and skin. Muscle Nerve. 1997;20:625-627.
40. Ruchoux MM, Chabriat H, Bousser MG, Baudrimont M, Tournier-Lasserve E. Presence of ultrastructural arterial lesions in muscle and skin vessels of patients with CADASIL. Stroke. 1994;25:2291-2292.
41. Chabriat H, Joutel A, Vahedi K, Iba-Zizen MT, Tournier-Lasserve E, Bousser MG. [CADASIL. cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalophathy]. Rev Neurol (Paris). 1997;153(6-7):376-385.
42. Ebke M, Dichgans M, Bergmann M, et al. CADASIL: skin biopsy allows diagnosis in early stages. Acta Neurol Scand. 1997;95:351-357.
43. Jen J, Cohen AH, Yue Q, et al. Hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS). Neurology. 1997;49:1322-1330.
44. Schultz A, Santoianni R, Hewan-Lowe K. Vasculopathic changes of CADASIL can be focal in skin biopsies. Ultrastruct Pathol. 1999;23:241-247.
45. Joutel A, Favrole P, Labauge P, et al. Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis. Lancet. 2001;358:2049-2051.
46. Ruchoux MM, Domenga V, Brulin P, et al. Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Am J Pathol. 2003;162:329-342.
47. Lacombe P, Oligo C, Domenga V, Tournier-Lasserve E, Joutel A. Impaired cerebral vasoreactivity in a transgenic mouse model of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy arteriopathy. Stroke. 2005;36:1053-1058.
48. Dubroca C, Lacombe P, Domenga V, et al. Impaired vascular mechanotransduction in a transgenic mouse model of CADASIL arteriopathy. Stroke. 2005;36:113-117.
49. Desmond DW, Moroney JT, Lynch T, Chan S, Chin SS, Mohr JP. The natural history of CADASIL: a pooled analysis of previously published cases. Stroke. 1999;30:1230-1233.
50. Trojano L, Ragno M, Manca A, Caruso G. A kindred affected by cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). A 2-year neuropsychological follow-up. J Neurol. 1998;245:217-222.
51. Lesnik Oberstein SA, van den Boom R, Middelkoop HA, et al. Incipient CADASIL. Arch Neurol. 2003;60:707-712.
52. Taillia H, Chabriat H, Kurtz A, et al. Cognitive alterations in non-demented CADASIL patients. Cerebrovasc Dis. 1998;8:97-101.
53. Amberla K, Waljas M, Tuominen S, et al. Insidious cognitive decline in CADASIL. Stroke. 2004;35:1598-1602.
54. Holtmannspotter M, Peters N, Opherk C, et al. Diffusion magnetic resonance histograms as a surrogate marker and predictor of disease progression in CADASIL: a two-year follow-up study. Stroke. 2005;36:2559- 2565.
55. Buffon F, Porcher R, Hernandez K, et al. Cognitive profile in CADASIL. J Neurol Neurosurg Psychiatry. 2006;77:175-180.
56. Peters N, Opherk C, Danek A, Ballard C, Herzog J, Dichgans M. The pattern of cognitive performance in CADASIL: a monogenic condition leading to subcortical ischemic vascular dementia. Am J Psychiatry. 2005;162:2078-2085.
57. Hedera P, Friedland RP. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: study of two American families with predominant dementia. J Neurol Sci. 1997;146:27-33.
58. Chabriat H, Tournier-Lasserve E, Vahedi K, et al. Autosomal dominant migraine with MRI white-matter abnormalities mapping to the CADASIL locus. Neurology. 1995;45:1086-1091.
59. Peters N, Herzog J, Opherk C, Dichgans M. A two-year clinical follow-up study in 80 CADASIL subjects: progression patterns and implications for clinical trials. Stroke. 2004;35:1603-1608.
60. Molko N, Pappata S, Mangin JF, et al. Diffusion tensor imaging study of subcortical gray matter in cadasil. Stroke. 2001;32:2049-2054.
61. Zekry D, Duyckaerts C, Belmin J, et al. The vascular lesions in vascular and mixed dementia: the weight of functional neuroanatomy. Neurobiol Aging. 2003;24:213-219.
62. Chabriat H, Joutel A, Vahedi K, Iba-Zizen MT, Tournier-Lasserve E, Bousser MG. [CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy): clinical features and neuroimaging]. Bull Acad Natl Med. 2000;184:1523-1531; discussion 1531-1533.
63. Kumar SK, Mahr G. CADASIL presenting as bipolar disorder. Psychosomatics. 1997;38:397-398.
64. Ahearn EP, Speer MC, Chen YT, et al. Investigation of Notch3 as a candidate gene for bipolar disorder using brain hyperintensities as an endophenotype. Am J Med Genet. 2002;114:652-658.
65. Aylward ED, Roberts-Willie JV, Barta PE, et al. Basal ganglia volume and white matter hyperintensities in patients with bipolar disorder. Am J Psychiatry. 1994;5:687-693.
66. Bhatia K, Marsden C. The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain. 1994;117:859-876.
67. Verin M, Rolland Y, Landgraf F, et al. New phenotype of the cerebral autosomal dominant arteriopathy mapped to chromosome 19: migraine as the prominent clinical feature. J Neurol Neurosurg Psychiatry. 1995;59:579-585.
68. Lagas PA, Juvonen V. Schizophrenia in a patient with cerebral autosomally dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL disease). Nord J Psychiatry. 2001;55:41-42.
69. Thomas N, Mathews T, Loganathan A. Cadasil: presenting as a mood disorder. Scott Med J. 2002;47:36-37.
70. Leyhe T, Wiendl H, Buchkremer G, Wormstall H. CADASIL: underdiagnosed in psychiatric patients? Acta Psychiatr Scand. 2005;111:392-396; discussion 396-397.
71. Tournier-Lasserve E, Iba-Zizen MT, Romero N, Bousser MG. Autosomal dominant syndrome with strokelike episodes and leukoencephalopathy. Stroke. 1991;22:1297-1302.
72. Chabriat H, Levy C, Taillia H, et al. Patterns of MRI lesions in CADASIL. Neurology. 1998;51:452-457.
73. Dichgans M, Filippi M, Bruning R, et al. Quantitative MRI in CADASIL: correlation with disability and cognitive performance. Neurology. 1999;52:1361-1367.
74. Chabriat H, Mrissa R, Levy C, et al. Brain stem MRI signal abnormalities in CADASIL. Stroke. 1999;30:457-459.
75. Coulthard A, Blank SC, Bushby K, Kalaria RN, Burn DJ. Distribution of cranial MRI abnormalities in patients with symptomatic and subclinical CADASIL. Br J Radiol. 2000;73:256-265.
76. Auer DP, Putz B, Gossl C, Elbel G, Gasser T, Dichgans M. Differential lesion patterns in CADASIL and sporadic subcortical arteriosclerotic encephalopathy: MR imaging study with statistical parametric group comparison. Radiology. 2001;218:443-451.
77. O'Sullivan M, Jarosz JM, Martin RJ, Deasy N, Powell JF, Markus HS. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology. 2001;56:628-634.
78. Markus HS, Martin RJ, Simpson MA, et al. Diagnostic strategies in CADASIL. Neurology. 2002;59:1134-1138.
79. Iwatsuki K, Murakami T, Manabe Y, et al. Two cases of Japanese CADASIL with corpus callosum lesion. Tohoku J Exp Med. 2001;195:135-140.
80. van Den Boom R, Lesnik Oberstein SA, van Duinen SG, et al. Subcortical lacunar lesions: an MR imaging finding in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Radiology. 2002;224:791-796.
81. Chabriat H, Pappata S, Poupon C, et al. Clinical severity in CADASIL related to ultrastructural damage in white matter: in vivo study with diffusion tensor MRI. Stroke. 1999;30:2637-2643.
82. Chabriat H. Diffusion histograms in CADASIL. Stroke. 2005;36:2526.
83. Mesulam M, Siddique T, Cohen B. Cholinergic denervation in a pure multi-infarct state: observations on CADASIL. Neurology. 2003;60:1183-1185.
84. Viswanathan A, Gray F, Bousser MG, Baudrimont M, Chabriat H. Cortical neuronal apoptosis in CADASIL. Stroke. 2006;37:2690-2695.
85. O'Sullivan M, Singhal S, Charlton R, Markus HS. Diffusion tensor imaging of thalamus correlates with cognition in CADASIL without dementia. Neurology. 2004;62:702-707.
86. O'Sullivan M, Barrick TR, Morris RG, Clark CA, Markus HS. Damage within a network of white matter regions underlies executive dysfunction in CADASIL. Neurology. 2005;65:1584-1590.
87. Vahedi K, Chabriat H, Levy C, Joutel A, Tournier-Lasserve E, Bousser MG. Migraine with aura and brain magnetic resonance imaging abnormalities in patients with CADASIL. Arch Neurol. 2004;61:1237-1240.
88. Society. IH. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;suppl 7:8.
89. Schon F, Martin RJ, Prevett M, Clough C, Enevoldson TP, Markus HS. "CADASIL coma": an underdiagnosed acute encephalopathy. J Neurol Neurosurg Psychiatry. 2003;74:249-252.
90. Le Ber I, Carluer L, Derache N, Lalevee C, Ledoze F, Defer GL. Unusual presentation of CADASIL with reversible coma and confusion. Neurology. 2002;59:1115-1116.
91. Feuerhake F, Volk B, Ostertag CB, et al. Reversible coma with raised intracranial pressure: an unusual clinical manifestation of CADASIL. Acta Neuropathol (Berl). 2002;103:188-192.
92. Requena I, Indakoetxea B, Lema C, Santos B, Garcia-Castineira A, Arias M. [Coma associated with migraine]. Rev Neurol. 1999;29:1048- 1051.
93. Fitzimons RB, Wolfenden WH. Migraine coma. Meningitic migraine with cerebral oedema associated with a new form of autosomal dominant cerebellar ataxia.. Brain. 1991;108:555-577.
94. Bousser MG, Tournier-Lasserve E. Summary of the proceedings of the First International Workshop on CADASIL. Paris, May 19-21, 1993. Stroke. 1994;25:704-707.
95. Malandrini A, Carrera P, Ciacci G, et al. Unusual clinical features and early brain MRI lesions in a family with cerebral autosomal dominant arteriopathy. Neurology. 1997;48:1200-1203.
96. Van Gerpen JA, Ahlskog JE, Petty GW. Progressive supranuclear palsy phenotype secondary to CADASIL. Parkinsonism Relat Disord. 2003;9:367-369.
97. Rufa A, De Stefano N, Dotti MT, et al. Acute unilateral visual loss as the first symptom of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Arch Neurol. 2004;61:577-580.
98. Ragno M, Tournier-Lasserve E, Fiori MG, et al. An Italian kindred with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Ann Neurol. 1995;38:231-236.
99. Lv H, Yao S, Zhang W, et al. [Clinical features in 4 Chinese families with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).]. Beijing Da Xue Xue Bao. 2004;36:496-500.
100. Sicurelli F, Dotti MT, De Stefano N, et al. Peripheral neuropathy in CADASIL. J Neurol. 2005;252:1206-1209.